Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012

Pages: 141 Published: January 01, 2012 Report Code: GDHC1087CTIDB

  • Overview
  • Contents
  • Tables
  • Figures
  • Listen
    Text to Speech Voices

GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2011" provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Breast Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Breast Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 8

Metastatic Breast Cancer 8

Report Guidance 8

Clinical Trials by Region 9

Clinical Trials by Country 10

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by BRIC Nations 17

Clinical Trials by G7 Nations 18

Clinical Trials in G7 Nations by Trial Status 19

Clinical Trials by E7 Nations 20

Clinical Trials in E7 Nations by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Unaccomplished Trials of Metastatic Breast Cancer 25

Subjects Recruited Over a Period of Time 33

Prominent Sponsors 34

Top Companies Participating in Metastatic Breast Cancer Therapeutics Clinical Trials 36

Prominent Drug Comparison 38

Clinical Trial Profiles 39

Clinical Trial Overview of Top Companies 39

GlaxoSmithKline plc 39

Clinical Trial Overview of GlaxoSmithKline plc 39

Eli Lilly and Company 42

Clinical Trial Overview of Eli Lilly and Company 42

F. Hoffmann-La Roche Ltd. 44

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 44

Novartis AG 47

Clinical Trial Overview of Novartis AG 47

Bristol-Myers Squibb Company 49

Clinical Trial Overview of Bristol-Myers Squibb Company 49

Pfizer Inc. 51

Clinical Trial Overview of Pfizer Inc. 51

AstraZeneca PLC 53

Clinical Trial Overview of AstraZeneca PLC 53

Amgen Inc. 55

Clinical Trial Overview of Amgen Inc. 55

Celgene Corporation 56

Clinical Trial Overview of Celgene Corporation 56

Sanofi 57

Clinical Trial Overview of Sanofi 57

Genentech, Inc. 58

Clinical Trial Overview of Genentech, Inc. 58

Taiho Pharmaceutical Co., Ltd. 59

Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 59

Intas Pharmaceuticals Ltd. 60

Clinical Trial Overview of Intas Pharmaceuticals Ltd. 60

Eisai Inc. 61

Clinical Trial Overview of Eisai Inc. 61

Boehringer Ingelheim GmbH 62

Clinical Trial Overview of Boehringer Ingelheim GmbH 62

US Oncology, Inc. 63

Clinical Trial Overview of US Oncology, Inc. 63

ARCAGY – GINECO 64

Clinical Trial Overview of ARCAGY – GINECO 64

Merck & Co., Inc. 65

Clinical Trial Overview of Merck & Co., Inc. 65

Johnson & Johnson 66

Clinical Trial Overview of Johnson & Johnson 66

Dr. Reddy's Laboratories Limited 67

Clinical Trial Overview of Dr. Reddy's Laboratories Limited 67

Clinical Trial Overview of Top Universities / Institutes / Hospitals 68

The University of Texas M. D. Anderson Cancer Center 68

Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 68

Memorial Sloan Kettering Cancer Center 72

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 72

Dana-Farber Cancer Institute 74

Clinical Trial Overview of Dana-Farber Cancer Institute 74

Vanderbilt-Ingram Cancer Center 75

Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 75

Sarah Cannon Research Institute 76

Clinical Trial Overview of Sarah Cannon Research Institute 76

University of Medicine and Dentistry New Jersey 77

Clinical Trial Overview of University of Medicine and Dentistry New Jersey 77

FUDAN University 78

Clinical Trial Overview of FUDAN University 78

Fred Hutchinson Cancer Research Center 79

Clinical Trial Overview of Fred Hutchinson Cancer Research Center 79

Southeastern Medical Oncology Center 80

Clinical Trial Overview of Southeastern Medical Oncology Center 80

Stanford University 81

Clinical Trial Overview of Stanford University 81

Sidney Kimmel Comprehensive Cancer Center 82

Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 82

Northwestern University 83

Clinical Trial Overview of Northwestern University 83

Mayo Clinic 84

Clinical Trial Overview of Mayo Clinic 84

European Organization for Research and Treatment of Cancer 85

Clinical Trial Overview of European Organization for Research and Treatment of Cancer 85

Southwest Oncology Group 86

Clinical Trial Overview of Southwest Oncology Group 86

Duke University 87

Clinical Trial Overview of Duke University 87

Washington University School of Medicine 88

Clinical Trial Overview of Washington University School of Medicine 88

Albert Einstein College of Medicine of Yeshiva University 89

Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University 89

University of Michigan Comprehensive Cancer Center 90

Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 90

New York University School of Medicine 91

Clinical Trial Overview of New York University School of Medicine 91

Five Key Clinical Profiles 92

Appendix 137

Abbreviations 137

Definitions 137

Research Methodology 139

Secondary Research 139

About GlobalData 140

Contact Us 140

Disclaimer 140

Source 141

List of Tables

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11

Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12

Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13

Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 14

Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15

Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16

Metastatic Breast Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 17

Metastatic Breast Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 18

Metastatic Breast Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19

Metastatic Breast Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 20

Metastatic Breast Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24

Metastatic Breast Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25

Metastatic Breast Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26

Metastatic Breast Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27

Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 33

Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 35

Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 37

Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 38

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 39

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 42

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 44

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 47

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 49

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 51

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 53

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 55

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 56

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 57

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012* 58

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012* 59

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Intas Pharmaceuticals Ltd., 2012* 60

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 61

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 62

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by US Oncology, Inc., 2012* 63

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCAGY – GINECO, 2012* 64

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 65

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 66

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2012* 67

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 68

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 72

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 74

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012* 75

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012* 76

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012* 77

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 78

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 79

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2012* 80

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 81

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 82

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 83

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 84

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 85

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012* 86

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 87

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2012* 88

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2012* 89

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012* 90

Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2012* 91

List of Figures

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11

Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12

Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13

Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14

Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15

Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16

Metastatic Breast Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17

Metastatic Breast Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 18

Metastatic Breast Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19

Metastatic Breast Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 20

Metastatic Breast Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23

Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24

Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 33

Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 34

Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 36

Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 38

GlobalData Methodology 139

$1000

Can be used by individual purchaser only

$3000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.